Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.
Saved in:
| Title: | Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder. |
|---|---|
| Authors: | Santoro JD; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.; Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA., Khoshnood MM; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA., Jafarpour S; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA., Nguyen L; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA., Boyd NK; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA., Vogel BN; Division of Neuroimmunology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA., Kammeyer R; Department of Neurology, Children's Hospital Colorado, Aurora, Colorado, USA., Patel L; Department of Neurology, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pharmacology, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Manning MA; Department of Genetics, Stanford University School of Medicine, Palo Alto, California, USA., Rachubinski AL; Department of Pharmacology, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Filipink RA; Division of Child Neurology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Baumer NT; Division of Developmental Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Santoro SL; Genetics and Metabolism Division, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA., Franklin C; Mater Research Institute-UQ, The University of Queensland, Brisbane, Queensland, Australia., Tamrazi B; Department of Radiology, Children's Hospital Los Angeles and Keck School of Medicine of the University of Southern California, Los Angeles, California, USA., Yeom KW; Department of Radiology, Stanford University School of Medicine, Palo Alto, California, USA., Worley G; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Espinosa JM; Department of Pharmacology, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Rafii MS; Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.; Alzheimer's Therapeutic Research Institute, Keck School of Medicine of the University of Southern California, San Diego, California, USA. |
| Source: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 1034-1045. Date of Electronic Publication: 2024 Feb 20. |
| Publication Type: | Multicenter Study; Journal Article |
| Journal Info: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-9503 |
|---|---|
| DOI: | 10.1002/acn3.52023 |
